Christopher Byrne on Muck Rack

Christopher Byrne

As seen in: Gay City News, LinkedIn, The New York Times, Color Research & Application, Daily Mail, HuffPost, Nature, Nature Reviews Gastroenterology & Hepatology, The Daily Mirror, The Guardian, Wiley and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Christopher

Contact Christopher, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Cardiovascular Disease Risk Prediction in Patients With Metabolic Dysfunction-Associated Steatohepatitis

|
By Christopher Byrne, Joe Hollinghurst, Margarida Augusto
| Wiley Online Library
1 Introduction Metabolic dysfunction-associated steatohepatitis (MASH), previously known as Non-alcoholic steatohepatitis (NASH) [1], is a severe form of metabolic dysfunction-associated steatotic liver disease (MASLD), with the additional complications of inflammation and liver damage [2]. The overall global prevalence of MASLD has already reached epidemic proportions (> 30%) [3], and prevalence continues to increase [4-7].
Open in Who Shared Issue with article?

Diagnostic Innovation and Models of Care to Improve Fibrosis Detection and Risk Stratification in Steatotic Liver Disease

|
By Christopher D. Byrneaj, Christopher Byrne, Nicola R Pugliese
| The Lancet
Keywords MASLD metALD Non-invasive tests Diagnostic innovation Fibrosis detection Risk stratification Models of care Blood-based biomarkers Diagnostic pathways Precision hepatology Abbreviations AI (Artificial intelligence) ALD (Alcohol-associated liver disease) BMI (Body mass index) CVD (Cardiovascular disease) EHR (Electronic health record) ELF (Enhanced Liver Fibrosis) EU (European Union) FIB-4 (Fibrosis-4 index) HCC (Hepatocellular carcinoma) HCP (Healthcare professional) MASH (Metabolic...
Open in Who Shared Issue with article?

MASLD prevalence, incidence and global aspects

|
By Christopher Byrne, Sarah Wild , Jeffrey V. Lazarus
| Springer
Rinella ME, Lazarus JV, Ratziu V et al (2023) A multisociety Delphi consensus statement on new fatty liver disease nomenclature. J Hepatol. https://doi.org/10.1016/j.jhep.2023.06.003 Article PubMed Google Scholar Zou H, Ma X, Pan W, Xie Y (2024) Comparing similarities and differences between NAFLD, MAFLD, and MASLD in the general U.S. population. Front Nutr 11:1411802.
Open in Who Shared Issue with article?
See all 781 licensed articles (892 Total)

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Get in touch with Christopher

Contact Christopher, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified